---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-001971"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:38:33.112912+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Texas Prostate hits 100th TULSA Procedure; volumes up 500% under new Medicare model

## Summary
- Texas Prostate, led by Dr. James Cochran, performed its 100th TULSA Procedure at Dallas Medical Center.
- Procedure volumes increased 500% after transitioning from private pay to a Medicare model via Dallas Medical Center.
- Dr. Cochran cited TULSA's MRI-guidance and thermography for broader treatment range and improved safety versus HIFU.
- CEO Arun Menawat said the model demonstrates a path for accelerating TULSA adoption across prostate care.

## SEC filing metadata
- accession: 0001171843-26-001971
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/0001171843-26-001971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001971/f8k_032726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-001971
- JSON: https://secwatch.observer/filing/0001171843-26-001971.json
- Plain text: https://secwatch.observer/filing/0001171843-26-001971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.